BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24611168)

  • 21. Towards new TB vaccines: What are the challenges?
    Dockrell HM
    Pathog Dis; 2016 Jun; 74(4):ftw016. PubMed ID: 26960944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progress towards development of an HIV vaccine: report of the AIDS Vaccine 2009 Conference.
    Ross AL; Bråve A; Scarlatti G; Manrique A; Buonaguro L
    Lancet Infect Dis; 2010 May; 10(5):305-16. PubMed ID: 20417413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant Mycobacterium bovis BCG as an HIV vaccine vector.
    Chapman R; Chege G; Shephard E; Stutz H; Williamson AL
    Curr HIV Res; 2010 Jun; 8(4):282-98. PubMed ID: 20353397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV. The modern era of HIV-1 vaccine development.
    Mascola JR
    Science; 2015 Jul; 349(6244):139-40. PubMed ID: 26160931
    [No Abstract]   [Full Text] [Related]  

  • 25. Advances and challenges in recombinant Mycobacterium bovis BCG-based HIV vaccine development: lessons learned.
    Kilpeläinen A; Maya-Hoyos M; Saubí N; Soto CY; Joseph Munne J
    Expert Rev Vaccines; 2018 Nov; 17(11):1005-1020. PubMed ID: 30300040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New tuberculosis vaccine development.
    Sacksteder KA; Nacy CA
    Expert Opin Biol Ther; 2002 Oct; 2(7):741-9. PubMed ID: 12387673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progress in HIV vaccine development.
    Hsu DC; O'Connell RJ
    Hum Vaccin Immunother; 2017 May; 13(5):1018-1030. PubMed ID: 28281871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials.
    McShane H; Pathan AA; Sander CR; Goonetilleke NP; Fletcher HA; Hill AV
    Tuberculosis (Edinb); 2005; 85(1-2):47-52. PubMed ID: 15687027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. INFECTIOUS DISEASES. Designer proteins produce potent HIV defense.
    Cohen J
    Science; 2015 Jun; 348(6241):1297. PubMed ID: 26089490
    [No Abstract]   [Full Text] [Related]  

  • 30. Germinal Center Lymphocyte Ratios and Successful HIV Vaccines.
    Gonzalez-Figueroa P; Roco JA; Vinuesa CG
    Trends Mol Med; 2017 Feb; 23(2):95-97. PubMed ID: 28089302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prime-boost immunization strategies for infectious diseases.
    McShane H
    Curr Opin Mol Ther; 2002 Feb; 4(1):23-7. PubMed ID: 11883691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current world literature.
    Curr Opin HIV AIDS; 2009 Sep; 4(5):453-7. PubMed ID: 20046137
    [No Abstract]   [Full Text] [Related]  

  • 33. [The application of recombinant Bacillus Calmette-Guérin vaccine and its vector in infectious disease].
    Zulpiya T; Ding J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2013 Oct; 30(5):1136-40. PubMed ID: 24459985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Skin side effects stymie advance of HIV vaccine.
    Cohen J
    Science; 2024 Mar; 383(6687):1044. PubMed ID: 38452071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospects for a globally effective HIV-1 vaccine.
    Excler JL; Robb ML; Kim JH
    Vaccine; 2015 Nov; 33 Suppl 4():D4-12. PubMed ID: 26100921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. European Union conference on poverty-related diseases research.
    Gryseels B; Zumla A; Troye-Blomberg M; Kieny MP; Quaglio G; Holtel A; Laang H; Romaris M; De Magistris MT; Nuez AN; Olesen OF; Ghalouci R; Lönnroth A
    Lancet Infect Dis; 2009 Jun; 9(6):334-7. PubMed ID: 19467472
    [No Abstract]   [Full Text] [Related]  

  • 37. HIV neutralizing antibodies reignite interest in vaccine.
    Waltz E
    Nat Biotechnol; 2012 Mar; 30(3):204-5. PubMed ID: 22398603
    [No Abstract]   [Full Text] [Related]  

  • 38. TRANSVAC workshop on standardisation and harmonisation of analytical platforms for HIV, TB and malaria vaccines: 'how can big data help?'.
    Dutruel C; Thole J; Geels M; Mollenkopf HJ; Ottenhoff T; Guzman CA; Fletcher HA; Leroy O; Kaufmann SHE
    Vaccine; 2014 Jul; 32(35):4365-4368. PubMed ID: 24950356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successes and failures in human tuberculosis vaccine development.
    Zenteno-Cuevas R
    Expert Opin Biol Ther; 2017 Dec; 17(12):1481-1491. PubMed ID: 28927311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The current status, challenges, and future developments of new tuberculosis vaccines.
    Gong W; Liang Y; Wu X
    Hum Vaccin Immunother; 2018 Jul; 14(7):1697-1716. PubMed ID: 29601253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.